Publications by authors named "Mariana Ferreira Lanna"

Background/objectives: Considering the large number of candidates in vaccine-testing studies against different pathogens and the amount of time spent in the preclinical and clinical trials, there is a pressing need to develop an improved in vivo system to quickly screen vaccine candidates. The model of a polyester-polyurethane sponge implant provides a rapid analysis of the specific stimulus-response, allowing the study of a compartmentalized microenvironment. The sponge implant's defined measurements were standardized as a compartment to assess the immune response triggered by the vaccinal antigen.

View Article and Find Full Text PDF
Article Synopsis
  • The sponge implant serves as a crucial model for investigating inflammatory responses by promoting the movement and growth of inflammatory cells, blood vessel formation, and tissue structure development.
  • Different mouse strains (Swiss, BALB/c, C57BL/6) exhibited distinct immune responses over time, with Swiss mice showing a mixed cytokine profile, BALB/c displaying early innate activation, and C57BL/6 maintaining a pro-inflammatory response.
  • Choosing the right mouse strain and time point for analysis helps to minimize bias in research outcomes, which is essential for applications like therapeutic biomolecule screening and antigen selection.
View Article and Find Full Text PDF

Visceral leishmaniasis (VL) is a severe disease caused by . Dogs are the parasite's main reservoir, favoring its transmission in the urban environment. The analysis of from infected dogs contributes to the identification of more virulent parasites, thereby supporting basic and applied studies such as vaccinal and therapeutic strategies.

View Article and Find Full Text PDF

The natural history of canine visceral leishmaniasis (CVL) has been well described, particularly with respect to the parasite load in different tissues and immunopathological changes according to the progression of clinical forms. The biomarkers evaluated in these studies provide support for the improvement of the tools used in developing vaccines against CVL. Thus, we describe the major studies using the dog model that supplies the rationale for including different biomarkers (tissue parasitism, histopathology, hematological changes, leucocytes immunophenotyping, cytokines patterns, and in vitroco-culture systems using purified T-cells subsets and macrophages infected with L.

View Article and Find Full Text PDF

The occurrence of inflammation and protein malnutrition is an aggravating risk factor for morbidity and mortality in the clinical setting. The green propolis, a natural product made by Apis mellifera bees from Baccharis dracunculifolia resin, has therapeutic potential to modulate chronic inflammation. However, its effect on inflammation in an impaired nutritional status is not known.

View Article and Find Full Text PDF

Background: In past years, many researchers have sought canine visceral leishmaniasis (CVL) prevention through the characterization of Leishmania antigens as vaccine candidates. Despite these efforts, there is still no efficient vaccine for CVL control.

Methods: In the present study, we performed a pre-clinical vaccine trial using BALB/c mice to compare the effects of the multicomponent LBSap vaccine with those of Leish-Tec® and Leishmune®.

View Article and Find Full Text PDF

In the studies presented here, dogs were vaccinated against Leishmania (Leishmania) chagasi challenge infection using a preparation of Leishmania braziliensis promastigote proteins and saponin as adjuvant (LBSap). Vaccination with LBSap induced a prominent type 1 immune response that was characterized by increased levels of interleukin (IL-) 12 and interferon gamma (IFN-γ) production by peripheral blood mononuclear cells (PBMC) upon stimulation with soluble vaccine antigen. Importantly, results showed that this type of responsiveness was sustained after challenge infection; at day 90 and 885 after L.

View Article and Find Full Text PDF